Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation

Blood

Volumn 123, Issue 8, 2014, Pages 1270-1278

  Fernandez Viña, Marcelo A ^a   Wang, Tao ^b   Lee, Stephanie J ^c   Haagenson, Michael ^d   Aljurf, Mahmoud ^e   Askar, Medhat ^f   Battiwalla, Minoo ^g   Baxter Lowe, Lee Ann ^h   Gajewski, James ⁱ   Jakubowski, Ann A ^j   Marino, Susana ^k   Oudshoorn, Machteld ^l   Marsh, Steven G E ^m   Petersdorf, Effie W ^c   Schultz, Kirk ⁿ   Turner, E Victoria ^o   Waller, Edmund K ^p   Woolfrey, Ann ^c   Umejiego, John ^d   Spellman, Stephen R ^d   Setterholm, Michelle ^q   more..

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^e King Faisal Specialty Hospital   (Saudi Arabia)

^f LERNER RESEARCH INSTITUTE   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^j MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^k UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^l LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^m UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁿ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^o ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^p EMORY UNIVERSITY HOSPITAL   (United States)

^q NATIONAL MARROW DONOR PROGRAM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ADVERSE OUTCOME; ALLELE; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA C ALLELE MISMATCH; HLA SYSTEM; HLA TYPING; HUMAN; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; NEWBORN; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; TREATMENT OUTCOME; UNRELATED DONORS; AGED; ALGORITHM; CHILD; GENETICS; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALGORITHMS; ALLELES; CHILD; CHILD, PRESCHOOL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA-C ANTIGENS; HUMANS; INFANT; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS; UNRELATED DONORS; YOUNG ADULT;

EID: 84899151037     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-10-532671     Document Type: Article

References (43)

1. Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med. 1985;313(13):765-771. (Pubitemid 15232310)
2. Saber W, Opie S, Rizzo JD, Zhang MJ, Horowitz MM, Schriber J. Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. Blood. 2012;119(17):3908-3916.
3. Arora M, Weisdorf DJ, Spellman SR, et al. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. J Clin Oncol. 2009;27(10):1644-1652.
4. Foeken LM, Green A, Hurley CK, Marry E, Wiegand T, Oudshoorn M; Donor Registries Working Group of the World Marrow Donor Association (WMDA). Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant. 2010;45(5):811-818.
5. Petz LD, Spellman SS, Gragert L. The underutilization of cord blood transplantation: extent of the problem, causes, and methods improvement. In: Broxmeyer HE, ed. Cord Blood: Biology, Transplantation, Banking, and Regulation. Bethesda, MD: AABB Press; 2011:557-584.
6. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004;104(7):1923-1930. (Pubitemid 39297840)
7. Lee SJ, Klein J, Haagenson M, et al. Highresolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110(13):4576-4583. (Pubitemid 351377826)
8. Woolfrey A, Klein JP, Haagenson M, et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(6):885-892.
9. Horan J, Wang T, Haagenson M, et al. Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. Blood. 2012;120(14):2918-2924.
10. Petersdorf EW, Anasetti C, Martin PJ, et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood. 2004;104(9):2976-2980. (Pubitemid 39434990)
11. Wade JA, Hurley CK, Takemoto SK, et al. HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation. Blood. 2007;109(9):4064-4070. (Pubitemid 46641762)
12. Duquesnoy R, Spellman S, Haagenson M, Wang T, Horowitz MM, Oudshoorn M. HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors. Biol Blood Marrow Transplant. 2008;14(9):1064-1071.
13. Spellman S, Klein J, Haagenson M, et al. Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012;18(5):739-746.
14. Askar M, Sobecks R, Morishima Y, et al. Predictions in the face of clinical reality: HistoCheck versus high-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease. Biol Blood Marrow Transplant. 2011;17(9):1409-1415.
15. Kawase T, Morishima Y, Matsuo K, et al Japan Marrow Donor Program. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood. 2007;110(7):2235-2241. (Pubitemid 47523140)
16. Marino SR, Lin S, Maiers M, et al. Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation. Bone Marrow Transplant. 2012;47(2):217-226.
17. Petersdorf EW, Malkki M, Horowitz MM, Spellman SR, Haagenson MD, Wang T. Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation. Blood. 2013;121(10):1896-1905.
18. Oudshoorn M, Doxiadis II, van den Berg-Loonen PM, Voorter CE, Verduyn W, Claas FH. Functional versus structural matching: can the CTLp test be replaced by HLA allele typing? Hum Immunol. 2002;63(3):176-184. (Pubitemid 34246050)
19. Wang H, Tokunaga K, Akaza T, Tadokoro K, Shibata Y, Juji T. Identification of HLA-C alleles using PCR-single-strand-conformation polymorphism and direct sequencing. Tissue Antigens. 1997;49(2):134-140. (Pubitemid 27084696)
20. Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernández-Viña MA. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol. 2001;62(9):1009-1030. (Pubitemid 32835065)
21. Farag SS, Bacigalupo A, Eapen M, et al KIR Study Group, Center for International Blood and Marrow Transplantation Research. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. Biol Blood Marrow Transplant. 2006;12(8):876-884. (Pubitemid 44070674)
22. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18(4):295-304.
23. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69(2):204-217. (Pubitemid 10036817)
24. Gratwohl A, Brand R, Niederwieser D, et al. Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation. J Clin Oncol. 2011;29(15):1980-1986.
25. Zhang X, Zhang MJ. SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models. Comput Methods Programs Biomed. 2011;101(1):87-93.
26. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695-706. (Pubitemid 29126745)
27. Gaynor JJ, Feuer EJ, Tan CC, et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc. 1993;88(422):400-409.
28. Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol. 2007;68(9):779-788. (Pubitemid 47379974)
29. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987;329(6139):506-512. (Pubitemid 17131093)
30. Saper MA, Bjorkman PJ, Wiley DC. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol. 1991;219(2):277-319.
31. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 1996;384(6605):134-141. (Pubitemid 26386462)
32. Sugimoto K, Murata M, Terakura S, Naoe T. CTL clones isolated from an HLA-Cw-mismatched bone marrow transplant recipient with acute graft-versus-host disease. J Immunol. 2009;183(9):5991-5998.
33. Pidala J, Wang T, Haagenson M, et al. Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality. Blood. 2013;122(22):3651-3658.
34. Hurley CK, Fernandez-Vina M, Hildebrand WH, et al. A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. Hum Immunol. 2007;68(1):30-40. (Pubitemid 46026882)
35. Baxter-Lowe LA, Maiers M, Spellman SR, et al. HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. Biol Blood Marrow Transplant. 2009;15(8):971-981.
36. Fernandez Vina MA, Hollenbach JA, et al. Tracking human migrations by the analysis of the distribution of HLA alleles, lineages and haplotypes in closed and open populations. Philos Trans R Soc Lond B Biol Sci. 2012;367(1590):820- 829.
37. Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med. 1996;334(5):281-285. (Pubitemid 26033083)
38. Lin MT, Gooley T, Hansen JA, et al. Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation. Blood. 2001;98(10):3172-3173.
39. Katagiri T, Shiobara S, Nakao S, et al. Mismatch of minor histocompatibility antigen contributes to a graft-versus-leukemia effect rather than to acute GVHD, resulting in long-term survival after HLA-identical stem cell transplantation in Japan. Bone Marrow Transplant. 2006;38(10):681-686. (Pubitemid 44669683)
40. Warren EH, Zhang XC, Li S, et al. Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. Blood. 2012;120(14):2796-2806.
41. Fernández-Viña MA, Klein JP, Haagenson M, et al. Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. Blood. 2013;121(22):4603-4610.
42. Campbell EM, du Toit E, Tongio MM, Urlacher A, Mayer S, Mayr WR. Antigen report: HLA-Cw3. In: Albert ED, ed. Histocompatibility Testing 1984: Report of the Ninth International Histocompatibility Workshop and Conference. Verlag, Berlin, Heidelberg, Germany: Springer; 1984:179-180.
43. Fürst D, Müller C, Vucinic V, et al. High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis. Blood. 2013;122(18):3220-3229.